Iron Levels in Systemic Lupus Erythematosus
In SLE patients, expect low serum iron with paradoxically normal-to-elevated ferritin (often >100 μg/L) due to chronic inflammation, creating a pattern consistent with anemia of chronic disease (ACD) or mixed iron deficiency/ACD.
Expected Laboratory Findings in Active SLE
Serum Iron Parameters
Serum iron is typically LOW in SLE patients, particularly during active disease 1. This correlates negatively with disease activity and inflammatory markers.
Ferritin levels are MISLEADINGLY ELEVATED despite true iron deficiency. As an acute phase reactant, ferritin rises with inflammation in SLE, masking underlying iron depletion 1. Studies show:
- Mean ferritin often exceeds normal ranges (>555 μg/L reported) 2
- Ferritin >100 μg/L can still reflect iron deficiency when inflammation is present 3, 4
- This creates diagnostic confusion when using traditional iron studies alone
Transferrin saturation is REDUCED (<20%), indicating functional iron restriction 3, 4.
Total iron binding capacity (TIBC) is DECREASED in approximately 48% of SLE patients, distinguishing this from pure iron deficiency anemia where TIBC would be elevated 5.
Anemia Patterns in SLE
The most common anemia types in SLE are:
- Mixed iron deficiency + ACD (58%) - the predominant pattern when properly assessed 1
- Pure ACD (26-36%) - when using accurate markers 6, 1
- Pure iron deficiency (16-32%) - less common than traditionally thought 6, 1
- Autoimmune hemolytic anemia - occurs but less frequently 1
Critical Diagnostic Pitfall
Standard ferritin cutoffs UNDERESTIMATE iron deficiency in SLE. When ferritin alone is used, pure ACD appears to affect 68% of patients, but this drops to 26% when soluble transferrin receptor (sTfR) is measured 1. This 42% discrepancy represents patients with coexisting iron deficiency missed by ferritin elevation.
Diagnostic Approach During Active Disease
In the presence of inflammation (elevated CRP/ESR):
- Ferritin <30 μg/L = absolute iron deficiency (rare in active SLE)
- Ferritin 30-100 μg/L = likely mixed iron deficiency + ACD 3, 4
- Ferritin >100 μg/L + transferrin saturation <20% = ACD pattern 3, 4
However, ferritin up to 100 μg/L may STILL indicate iron deficiency when inflammation is present 3, 4. This is the key threshold to remember.
Superior Diagnostic Markers
Soluble transferrin receptor (sTfR) is the most reliable marker for detecting true iron deficiency in SLE, as it:
- Remains elevated in iron deficiency regardless of inflammation 1
- Is NOT affected by acute phase reactions 1
- Correctly identifies the 58% of patients with mixed deficiency that ferritin misses 1
- Correlates with clinical response to iron therapy 1
Hepcidin levels provide additional diagnostic value:
- 40% of iron deficiency anemia patients have hepcidin <10 ng/mL
- 48% of ACD patients have hepcidin >10 ng/mL 6
- Hepcidin better distinguishes anemia types when ferritin is inconclusive 6
- Unlike ferritin, hepcidin does NOT correlate significantly with inflammatory markers in APS/SLE 6
Clinical Correlations
Higher ferritin levels (≥100 μg/L) associate with:
- Increased thrombosis risk (p=0.017) 6
- Fetal losses in antiphospholipid syndrome (p=0.034) 6
- Higher disease activity 2
Lower serum iron correlates with:
- Worse WHO functional class (r=-0.409) 5
- Reduced exercise capacity on 6-minute walk test (r=0.427) 5
- Decreased cardiac function (TAPSE, r=0.388) 5
Monitoring Recommendations
Based on EULAR guidelines for SLE monitoring 7:
- Assess hemoglobin and iron parameters at each clinic visit
- Severe anemia associates with organ involvement and worse prognosis
- Thrombocytopenia and lymphopenia correlate with renal disease progression
The inflammatory state in SLE fundamentally alters iron metabolism through increased hepcidin, creating functional iron restriction even when total body iron stores may be adequate. This explains why serum iron drops while ferritin paradoxically rises, and why sTfR or hepcidin measurements are essential for accurate diagnosis rather than relying on ferritin alone.